Aquestive Therapeutics reports 2024 annual meeting voting results

Aquestive Therapeutics, Inc.

Elected Santo J. Costa, Julie Krop, and Marco Taglietti as Class III directors with 24.9M, 21.6M, and 24.9M votes for.
Non-binding advisory vote on executive compensation approved: 23.6M for, 1.6M against.
Advisory vote frequency set at one year (24.6M for).
Ratified KPMG as independent auditor for FY 2024: 50.7M for, 0.9M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.